Literature DB >> 4133781

Anti-mitotic activity of bleomycin: time of action in the mammalian cell cycle.

D N Wheatley, G C Mueller, K Kajiwara.   

Abstract

Bleomycin inhibits cell division in HeLa S-3 and other mammalian epithelial cell lines. Its effect on suspension cultured cells is far greater than on monolayer cells; this was found to be due partly to the absence of divalent ions. Other mammalian epithelial lines in suspension culture are very sensitive but fibroblastic cells (BHK 21/C13/DWS-3) grown under identical conditions are relatively insensitive. This study has established that bleomycin is a powerful anti-mitotic agent during the G(2) phase but it does not prevent prophase cells from completing a normal mitotic division. Its ability to suppress DNA synthesis contributes little to the inhibition of cell cycling.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4133781      PMCID: PMC2008994          DOI: 10.1038/bjc.1974.48

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  24 in total

1.  Mechanism of action of bleomycin. Studies with the growing culture of bacterial and tumor cells.

Authors:  H Suzuki; K Nagai; H Yamaki; N Tanaka; H Umezawa
Journal:  J Antibiot (Tokyo)       Date:  1968-06       Impact factor: 2.649

2.  The distribution of 3H-bleomycin in mouse tissue.

Authors:  H Umezawa; M Ishizuki; S Hori; H Chimura; T Takeuchi
Journal:  J Antibiot (Tokyo)       Date:  1968-11       Impact factor: 2.649

3.  Modes of action of phleomycin, bleomycin and formycin on HeLa S3 cells in synchronized culture.

Authors:  T Kunimoto; M Hori; H Umezawa
Journal:  J Antibiot (Tokyo)       Date:  1967-09       Impact factor: 2.649

4.  Primary site of reaction in the in vitro complex of phleomycin in DNA.

Authors:  P Pietsch; H Garrett
Journal:  Nature       Date:  1968-08-03       Impact factor: 49.962

5.  Biological studies on individual bleomycins.

Authors:  H Umezawa; M Ishizaka; K Kimura; J Iwanaga; T Takeuchi
Journal:  J Antibiot (Tokyo)       Date:  1968-10       Impact factor: 2.649

6.  Changes in patterns of protein synthesis during the mammalian cell cycle.

Authors:  G M Kolodny; P R Gross
Journal:  Exp Cell Res       Date:  1969-07       Impact factor: 3.905

7.  Lethal effect of phleomycin in different stages of the division cycle of HeLa cells.

Authors:  B Djordjevic; J H Kim
Journal:  Cancer Res       Date:  1967-12       Impact factor: 12.701

8.  New antibiotics, bleomycin A and B.

Authors:  H Umezawa; K Maeda; T Takeuchi; Y Okami
Journal:  J Antibiot (Tokyo)       Date:  1966-09       Impact factor: 2.649

9.  Phleomycin, an inhibitor of replication of HeLa cells.

Authors:  K Kajiwara; U H Kim; G C Mueller
Journal:  Cancer Res       Date:  1966-02       Impact factor: 12.701

10.  Activity and toxicity of bleomycin.

Authors:  M Ishizuka; H Takayama; T Takeuchi; H Umezawa
Journal:  J Antibiot (Tokyo)       Date:  1967-01       Impact factor: 2.649

View more
  3 in total

1.  Comparison of the response of synchronized HeLa cells to talisomycin and bleomycin.

Authors:  C K Mirabelli; S T Crooke
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

2.  Disodium Cromolyn and Anti-podoplanin Antibodies Strongly Inhibit Growth of BHK 21/C13-derived Fibrosarcoma in a Chick Embryo Chorioallantoic Membrane Model.

Authors:  Anca Maria Cimpean; Dusan Lalošević; Vesna Lalošević; Pavle Banović; Marius Raica; Ovidiu Alexandru Mederle
Journal:  In Vivo       Date:  2018 Jul-Aug       Impact factor: 2.155

Review 3.  Emerging Therapeutic Targets Against Toxoplasma gondii: Update on DNA Repair Response Inhibitors and Genotoxic Drugs.

Authors:  Sergio O Angel; Laura Vanagas; Diego M Ruiz; Constanza Cristaldi; Ana M Saldarriaga Cartagena; William J Sullivan
Journal:  Front Cell Infect Microbiol       Date:  2020-06-12       Impact factor: 5.293

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.